For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Eyegene Inc.

USPTO Granted Patents = 11

EPO Patents = 5

Forward Citations = 12

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Yang Je Cho (7 out of 8 patents)

Yang-Je Cho (4 out of 4 patents)

Na Gyong Lee (4 out of 4 patents)

4. Jin-Wook Jang (3 out of 4 patents)

5. Oh-Woong Kwon (3 out of 3 patents)

6. Jin Wook Jang (3 out of 5 patents)

7. Doo Sik Kim (3 out of 4 patents)

8. Won Il Yoo (3 out of 3 patents)

9. Kwangsung Kim (2 out of 2 patents)

10. Doo-Sik Kim (2 out of 9 patents)

11. Hyeong Joon Lim (2 out of 3 patents)

12. Won-Il Yoo (2 out of 2 patents)

13. Soo-Mee Kwon (2 out of 2 patents)

14. Hyeong-Joon Lim (2 out of 2 patents)

15. Bo Young Ahn (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 10918709 - Immune modulator and vaccine composition containing the same (2021-02-16),

2. 10874733 - Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same (2020-12-29),

3. RE48023 - Method for treating vascular-related disease (2020-06-01),

4. 9572877 - Vaccine for inducing an improved immune reaction (2017-02-21),

5. 9566323 - Vaccine for cervical cancer (2017-02-14),

6. 9290542 - Pharmaceutical composition for preventing or treating arteriosclerosis (2016-03-22),

7. 9101581 - Method for treating vascular-related disease (2015-08-11),

8. 8883987 - Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides (2014-11-11),

9. 8372811 - Composition for treating retinopathy or glaucoma comprising thrombin derived peptides (2013-02-12),

10. 7897739 - Method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof (2011-03-01),

11. 7507802 - Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides (2009-03-24),

Eyegene Inc. is a biotechnology company focused on developing gene therapies for inherited retinal diseases. Our mission is to provide innovative treatments to improve the quality of life for patients with genetic vision disorders. With a team of experienced researchers and state-of-the-art technology, we are at the forefront of genetic medicine and are dedicated to advancing the field of ocular gene therapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#319 in Seoul

#966 in South Korea

#50,241 in the World

Seoul, South Korea

Eyegene Inc.

Forward Citations = 12

32 inventors:

Yang Je Cho (7 out of 8 patents)

Yang-Je Cho (4 out of 4 patents)

Na Gyong Lee (4 out of 4 patents)

4. Jin-Wook Jang (3 out of 4 patents)

5. Oh-Woong Kwon (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…